Worth Peripherals Q1FY27 Results: Profit Rises, Subsidiary Secures Funding
Worth Peripherals Limited reported its Q1FY27 results. The company approved the appointment of RS Mantri And Associates as Secretarial Auditor for five years. Its subsidiary, Worth Wellness, commenced commercial production and received ₹30 crore via equity allotment, converting a loan. Worth Peripherals also approved a ₹20 crore inter-corporate loan to the subsidiary.
The commencement of commercial production at a new facility, significant equity infusion into the subsidiary, and approval of a substantial inter-corporate loan are material events that will likely have a significant impact on the company's future performance and operational capacity.
The company reported positive financial results, the commencement of commercial production at its subsidiary's new facility, and strategic financial decisions like equity allotment and inter-corporate loans, all indicating growth and operational progress.
Worth Peripherals Limited announced its unaudited financial results for the quarter ended June 30, 2026. The company's Board of Directors, after review and recommendation by the Audit Committee, approved the standalone and consolidated financial results. Concurrently, the Board approved the appointment of M/s. RS Mantri And Associates as the Secretarial Auditor for a term of five years, commencing from the conclusion of the ensuing Annual General Meeting until the conclusion of the 35th AGM in 2031, subject to shareholder approval.
Furthermore, Worth Wellness Private Limited, a wholly-owned subsidiary, commenced commercial production at its new manufacturing facility in Indore on August 1, 2026. This facility is equipped with advanced technology and automation, enhancing the subsidiary's manufacturing capabilities. The subsidiary also received approval for the allotment of 60,00,000 equity shares to the holding company, Worth Peripherals Limited, at an issue price of ₹50 per share, aggregating to ₹30 crore. This conversion of outstanding loan into equity was approved by the Board of Worth Wellness Private Limited on August 4, 2026. Additionally, the Board of Worth Peripherals Limited approved an inter-corporate loan of ₹20 crore to Worth Wellness Private Limited to meet its funding requirements.
The company also informed that the date of its Annual General Meeting for the financial year ended March 31, 2026, and the record date for final dividend, e-voting, and other related matters will be announced in due course. The meeting of the Board of Directors commenced at 11:00 AM and concluded at 02:30 PM on August 4, 2026.
What to do with a filing like this
Worth Peripherals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Worth Peripherals Limited. Read the original for the full detail.